Annual Total Long Term Liabilities
N/A
December 31, 2024
Summary
- ESPR annual total long term liabilities is not available.
Performance
ESPR Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Long Term Liabilities
N/A
December 1, 2024
Summary
- ESPR quarterly total long term liabilities is not available.
Performance
ESPR Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
ESPR Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
ESPR Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
Esperion Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $518.45 M(-0.5%) |
| Jun 2024 | - | $521.20 M(+3.7%) |
| Mar 2024 | - | $502.85 M(-0.3%) |
| Dec 2023 | $504.57 M(+5.2%) | $504.57 M(+2.2%) |
| Sep 2023 | - | $493.60 M(-1.2%) |
| Jun 2023 | - | $499.43 M(+2.8%) |
| Mar 2023 | - | $486.00 M(+1.4%) |
| Dec 2022 | $479.41 M(-5.1%) | $479.41 M(-8.6%) |
| Sep 2022 | - | $524.58 M(+2.2%) |
| Jun 2022 | - | $513.40 M(+0.1%) |
| Mar 2022 | - | $512.81 M(+1.5%) |
| Dec 2021 | $505.18 M(+42.2%) | $505.18 M(-0.8%) |
| Sep 2021 | - | $509.48 M(+1.5%) |
| Jun 2021 | - | $502.13 M(+11.6%) |
| Mar 2021 | - | $450.11 M(+26.7%) |
| Dec 2020 | $355.32 M(+176.7%) | $355.32 M(+114.0%) |
| Sep 2020 | - | $166.06 M(+3.2%) |
| Jun 2020 | - | $160.98 M(+2.9%) |
| Mar 2020 | - | $156.44 M(+21.8%) |
| Dec 2019 | $128.42 M(>+9900.0%) | $128.42 M(-0.6%) |
| Sep 2019 | - | $129.24 M(+3.3%) |
| Jun 2019 | - | $125.17 M(+8550.2%) |
| Mar 2019 | - | $1.45 M(>+9900.0%) |
| Dec 2018 | $0.00 | $0.00(0.0%) |
| Sep 2018 | - | $0.00(0.0%) |
| Jun 2018 | - | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2017 | - | $0.00(-100.0%) |
| Jun 2017 | - | $140.00 K(-76.1%) |
| Mar 2017 | - | $585.00 K(-42.8%) |
| Dec 2016 | $1.02 M(-62.0%) | $1.02 M(-29.6%) |
| Sep 2016 | - | $1.45 M(-22.4%) |
| Jun 2016 | - | $1.87 M(-18.0%) |
| Mar 2016 | - | $2.28 M(-15.1%) |
| Dec 2015 | $2.69 M(-36.5%) | $2.69 M(-12.8%) |
| Sep 2015 | - | $3.08 M(-11.2%) |
| Jun 2015 | - | $3.47 M(-9.9%) |
| Mar 2015 | - | $3.85 M(-8.9%) |
| Dec 2014 | $4.23 M(>+9900.0%) | $4.23 M(-9.5%) |
| Sep 2014 | - | $4.68 M(-5.0%) |
| Jun 2014 | - | $4.92 M(>+9900.0%) |
| Mar 2014 | - | $0.00(0.0%) |
| Dec 2013 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2013 | - | $0.00(0.0%) |
| Jun 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00(-100.0%) |
| Dec 2012 | $7.53 M(+9.2%) | $7.53 M |
| Dec 2011 | $6.90 M(-10.8%) | - |
| Dec 2002 | $7.73 M(+41.0%) | - |
| Dec 2001 | $5.48 M(+81.1%) | - |
| Dec 2000 | $3.03 M(+32.5%) | - |
| Dec 1999 | $2.28 M | - |
FAQ
- What is the all time high annual total long term liabilities for Esperion Therapeutics?
- What is the all time high quarterly long term liabilities for Esperion Therapeutics?
What is the all time high annual total long term liabilities for Esperion Therapeutics?
Esperion Therapeutics all-time high annual total long term liabilities is $505.18 M
What is the all time high quarterly long term liabilities for Esperion Therapeutics?
Esperion Therapeutics all-time high quarterly total long term liabilities is $524.58 M